Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study

スポンサーリンク

概要

• 論文の詳細を見る

著者

• SHIRAKI Masataka

  Research Institute and Practice for Involutional Diseases

• OHATA Masahiro

  Department of Neurosurgery,School of Medicine,Tokyo Medical

• FUJITA Takuo

  Calcium Research Institute

• ORIMO HAJIME

  Tokyo Metropolitan Geriatric Medical Centre

• Morii Hirotoshi

  Second Department of Internal Medicine, Osaka City University Medical School

• Minaguchi Hiroshi

  Japan Osteoporosis Society

• Morii Hirotoshi

  Second Department Of Internal Medicine Osaka City University Medical School

• ORIMO Hajime

  Health Science University

• Orimo Hajime

  Tokyo Metropolitan Geriatric Hospital

• TOMITA Akio

  Aichi Medical University

• TOMITA Akio

  Department of Clinical Laboratories, Aichi Medical University

• Shintani Masafumi

  Department Of Obstetrics And Gynecology Narakenritsu Mimuro Hospital

• Minaguchi H

  Department Of Obstetrcs And Gynecology Yokohama City University School Of Medicine

• Tomita Akio

  Department Of Clinical Laboratories Aichi Medical University

• Ohata Masahiro

  Department Of Internal Medicine Wakayama Medical College Kihoku Branch Hospital

• Orimo Hajime

  Department Of Geriatrics Faculty Of Medicine University Of Tokyo

• Orimo Hajime

  General Research Committee For Prevention Of Osteoporosis Ministry Of Health And Welfare Tokyo Metro

• Shiraki Masataka

  Department Of Internal Medicine Research Institute And Practice For Involutional Diseases

• Shiraki Masataka

  Research Institute And Practice For Involutional Disease

• MORII HIROTOSHI

  Second Department of Internal Medicine Osaka City University

• OHATA MASAHIRO

  Department of Geriatrics University of Tokyo Faculty of Medicine

関連論文

• Association of a single nucleotide polymorphism in the constitutive androstane receptor gene with bone mineral density
• Association of a Sequence Variation in the Gene Encoding Adiponectin Receptor 1 (ADIPOR1) with Body Mass Index in the Japanese Population
• Association of a single nucleotide polymorphism in the steroid and xenobiotic receptor (SXR) gene (IVS1-579A/G) with bone mineral density
• Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women
• A-32. Dynamic Study on Cerebrospinal Fluid Circulation After Subarachnoid Hemorrhage : Second report
• S-II-7. Studies on Cerebrospinal Fluid Circulation Following Subarachnoid Hemorrhage
• Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1α-OH-vitamin D_3 (alfacalcidol) for treatment of postmenopausal bone loss
• α_vβ_3 Integrin ligands enhance volume-sensitive calcium influx in mechanically stretched osteocytes
• Clinical trial of risedronate in Japanese volunteers : a study on the effects of timing of dosing on absorption
• Haplotype analysis of the human collectin placenta 1 (hCL-P1) gene
• Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis
• -0146- Role of endothelium in hypotensive action of acetylcholine and bradylinin in spontaneously hypertensive rat.(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
• Suppressed prostaglandin 12 production in endothelial cells from spontaneously hypertensive (SHR) rat
• Efficacy and safety of long-term oral falecalcitriol treatment in patients with renal osteodystrophy
• Role of activin-A and follistatin in foam cell formation of THP-1 macrophages
• Association of a single nucleotide polymorphism in the secreted frizzled-related protein 4 (sFRP4) gene with bone mineral density
• Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women
• Association of a single-nucleotide polymorphism in the promoter region of leukemia inhibitory factor receptor gene with low bone mineral density in adult women
• Clinical trial of in-situ hybridization method for the rapid diagnosis of sepsis
• Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density
• Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women
• Association of the -381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss
• Idiopathic portal hypertension associated with high serum titer of autoantibodies and liver dysfunction
• A1330V Variant of the Low-density Lipoprotein Receptor-related Protein 5 (LRP5) Gene Decreases Wnt Signaling and Affects the Total Body Bone Mineral Density in Japanese Women
• The synergistic effect of bone mineral density and methylenetetrahydrofolate reductase (MTHFR) polymorphism (C677T) on fractures
• Association of a single nucleotide polymorphism in Wnt10b gene with bone mineral density
• The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria : prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis
• A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate : a randomized, double-masked trial
• Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis : a 3-year follow-up study
• Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women
• A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density
• Diagnostic criteria for primary osteoporosis: year 2000 revision
• Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus
• Linkage of interleukin 6 locus to human osteopenia by sibling pair analysis
• Identification of a novel polymorphism of estrogen receptor-α gene that is associated with calcium excretion in urine
• Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
• A Placebo-Controlled, Single-Blind Study to Determine the Appropriate Alendronate Dosage in Postmenopausal Japanese Patients with Osteopotosis
• Effect of elcatonin on involutional osteoporosis
• Analgesic effect of etidronate on degenerative joint disease
• Fall of skin impedance and bone and joint pain
• Increase of intestinal calcium absorption and bone mineral density by heated algal ingredient(HAI)in rats
• Comparison of antiresorptive activities of ipriflavone, an isoflavone derivative, and elcatonin, an eel carbocalcitonin
• A three-year comparative trial in osteoporosis treatment: Effect of combined alfacalcidol and elcatonin
• Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
• Efficacy of low-dose, intermittent eel calcitonin treatment for osteoporosis
• Association of estrogen receptor β (ESR2) gene polymorphism with blood pressure
• Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures
• Efficacy and tolerability of once-weekly administration of 17.5mg risedronate in Japanese patients with involutional osteoporosis : a comparison with 2.5-mg once-daily dosage regimen
• Diagnostic criteria of primary osteoporosis
• Synergistic Enhancement by 12-O-Tetradecanoylphorbol-13-acetate and Dibutyryl cAMP of 1α, 25-Dihydroxyvitamin D_3 Actionin Human Promyelocytic Leukemic HL-60 Cells
• Effects of GnRH on Protein Kinase C Activity, Ca^ Mobilization and Steroidogenesis of Human Granulosa Cells
• Association of Bone Metabolism Regulatory Factor Gene Polymorphisms With Susceptibility to Ossification of the Posterior Longitudinal Ligament of the Spine and Its Severity
• Efficacy and safety of oral falecalcitriol in reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism
• Saccharated Ferric Oxide-Induced Osteomalacia in Japan: Iron-Induced Osteopathy Due to Nephropathy
• Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese women
• Validation of the Japanese Osteoporosis Quality of Life Questionnaire
• Bone mass effects of a Smad6 gene polymorphism in Japanese postmenopausal women
• Association of a Single Nucleotide Polymorphism in the Insulin-Like Growth Factor-1 Receptor Gene With Spinal Disc Degeneration in Postmenopausal Japanese Women
• Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis : a double-blind, randomized study
• Changes of serum calcitonin in stress load
• Hypoxemia is a risk factor for bone mass loss
• Areal bone mineral density and bone phosphatase activities in experimental diabetes mellitus
• Effects of phosphorus-containing calcium preparation (bone meal powder) and calcium carbonate on serum calcium and phosphorus in young and old healthy volunteers: a double-blinded crossover study
• Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis : a randomized prospective study
• A polymorphic variant at the Werner helicase(WRN)gene is associated with bone density, but not spondylosis, in postmenopausal women
• Effect of calcium supplementation as oyster shell heated in vacuo on metabolism and survival of rats
• Association between bone loss and promoter polymorphism in the IL-6 gene in elderly Japanese women with hip fracture
• The Relationship Between Back Pain and Future Vertebral Fracture in Postmenopausal Women
• High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment
• Association of amino acid variation (Trp64Arg) in the beta3-adrenergic receptor gene with bone mineral density
• Ethnic difference in contribution of alleles of the interleukin-1 receptor antagonist gene to predisposition to osteoporosis
• Insulin Secretion in Patients with Hyperthyroidism: in Relation to Abnormalities in Carbohydrate Metabolism
• Closer Correlation between Serum Triiodothyronine and Basal Metabolic Rate during Antithyroid Drug Treatment in Patients with Graves Disease
• Statement on the diagnosis and management of osteoporosis from the Consensus Development Conference at the Second International Conference on Osteoporosis,Osaka 1997
• A Case Report on Disequilibrium Hypercalcemia in Hyperthyroidism : Comparison of Calcium Metabolism with Other Patients with Hyperthyroidism
• Effect of 1α-Hydroxyvitamin D_3 on Loss of Bone Mineral Density Immediately after Artificial Menopause
• Effect of Corticosteroids in 10 Cases of Methimazole-Induced Agranulocytosis
• ASSOCIATION OF ESTROGEN RECEPTOR DINUCLEOTIDE REPEAT POLYMORPHISM WITH OSTEOPOROSIS
• Enzymatic Hydrolysis of 125I-Labeled Parathyroid Hormone
• EFFECT OF AGE AND THYROCALCITONIN ON MYOCARDIAL CHANGES INDUCED BY SODIUM SULFAACETYLTHIAZOLE
• PREVENTION OF EXPERIMENTAL BONE ATROPHY BY THYROCALCITONIN
• A TEST ON THE RECOVERY FROM HYPERCALCEMIA FOR EVALUATION OF THYROCALCITONIN ACTIVITY IN MAN
• SERUM CALCIUM RESPONSE TO DISODIUM ETHYLENDIAMINE-TETRAACETATE (Ca-Na2-EDTA) AS A SIMPLE RAPID DIAGNOSTIC TEST FOR HYPOPARATHYROIDISM
• Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D_3 load in Japanese subjects
• Fall of blood ionized calcium on watching a provocative TV program and its prevention by active absorbable algal calsium (AAA Ca)
• Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis
• Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment
• Changes of regional distribution of bone mineral according to age. gender, and activity
• Calcium supplementation and parathyroid hormone
• Heated oyster shell with algal ingredient (AAACa) decreases urinary oxalate excretion
• Global assessment of risk factors for osteoporosis
• Calcium bioavailability from heated oyster shell-seaweed calcium (active absorbable algae calcium) as assessed by urinary calcium excretion
• Calcium paradox disease:Calcium deficiency prompting secondary hyperparathyroidism and cellular calcium overload
• Degenerative joint disease:An example of calcium paradox
• Effect of disuse on bone mineral content, lean mass, and fat mass in osteoarthritic patients
• Raloxifene: Basic Science to Clinical Outcomes
• Preventive Effect of Salmon Calcitonin on Restraint-Induced Gastric Ulcer in Rats
• A Case Report of Turner's Sydrome with Ring X Chromosome
• Bone Mineral Loss in Patients on Maintenance Hemodialysis with Hyperphosphatemia Treated with 1α-Hydroxycholecalciferol and Calcium Carbonate
• Breast arterial calcification and hypertension associated with vertebral fracture

もっと見る 閉じる

スポンサーリンク